Insider · CIK 0001292834

Hochman David P

CIK 0001292834 Name as filed on the most recent filing

Filed as Hochman David P (41)

52 transaction lines · from 41 filings · filed 2006-06-15 to 2026-06-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

52 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-06-01 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 19,150, acquired Open Form 4 filing 0001104659-26-069510
2026-05-15 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 18,850, acquired Open Form 4 filing 0001104659-26-063510
2026-03-13 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 42,900, acquired Open Form 4 filing 0001104659-26-028554
2025-11-14 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 20,350, acquired Open Form 4 filing 0001104659-25-113235
2025-08-21 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 14,940, acquired Open Form 4 filing 0001104659-25-082635
2025-08-04 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 55,000, acquired Open Form 4 filing 0001104659-25-073743
2024-12-23 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 18,640, acquired Open Form 4 filing 0001104659-24-131767
2024-12-18 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 24,550, acquired Open Form 4 filing 0001104659-24-130007
2024-09-25 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 4 lines 35,630, acquired Open Form 4 filing 0001104659-24-103002
2024-09-24 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 12,275, acquired Open Form 4 filing 0001104659-24-103002
2024-08-14 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 14,600, acquired Open Form 4 filing 0001104659-24-090181
2024-06-25 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 6,950, acquired Open Form 4 filing 0001104659-24-075169
2024-05-17 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 15,450, acquired Open Form 4 filing 0001104659-24-064004
2024-05-16 P, Open-market purchase Orchestra BioMed Holdings, Inc.OBIO 9,500, acquired Open Form 4 filing 0001104659-24-064004
2020-12-04 P, Open-market purchase Motus GI Holdings, Inc.MOTS 4,965, acquired Open Form 4 filing 0001213900-20-041228
2019-07-01 P, Open-market purchase Motus GI Holdings, Inc.MOTS 30,000, acquired Open Form 4 filing 0001213900-19-011860
2019-03-15 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 13,958, acquired Open Form 4 filing 0001209191-19-019885
2018-12-24 P, Open-market purchase Motus GI Holdings, Inc.MOTS 54,000, acquired Open Form 4 filing 0001615774-18-014984
2018-11-16 P, Open-market purchase Motus GI Holdings, Inc.MOTS 52,350, acquired Open Form 4 filing 0001615774-18-013100
2018-05-17 P, Open-market purchase Motus GI Holdings, Inc.MOTS 27,450, acquired Open Form 4 filing 0001615774-18-004110
2018-05-14 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 27,375, acquired Open Form 4 filing 0001209191-18-030144
2018-03-14 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 33,325, acquired Open Form 4 filing 0001209191-18-019763
2018-02-16 P, Open-market purchase Motus GI Holdings, Inc.MOTS 2 lines 575,000, acquired Open Form 4 filing 0001493152-18-002412
2017-11-15 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 32,750, acquired Open Form 4 filing 0001209191-17-061052
2017-11-13 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 34,500, acquired Open Form 4 filing 0001209191-17-060534
2017-11-10 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 70,800, acquired Open Form 4 filing 0001209191-17-060177
2017-05-11 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 21,012, acquired Open Form 4 filing 0001209191-17-031751
2016-11-18 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 69,960, acquired Open Form 4 filing 0001209191-16-151350
2016-08-22 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 6,786, acquired Open Form 4 filing 0001209191-16-138122
2016-01-22 P, Open-market purchase Naked Brand Group Inc.NAKD 7,875, acquired Open Form 4 filing 0001062993-16-007261
2016-01-06 P, Open-market purchase Naked Brand Group Inc.NAKD 2,340, acquired Open Form 4 filing 0001062993-16-006947
2016-01-05 P, Open-market purchase Naked Brand Group Inc.NAKD 15,522, acquired Open Form 4 filing 0001062993-16-006947
2015-12-30 P, Open-market purchase Naked Brand Group Inc.NAKD 11,790, acquired Open Form 4 filing 0001062993-16-006899
2015-12-23 P, Open-market purchase Naked Brand Group Inc.NAKD 70,000, acquired Open Form 4 filing 0001062993-15-006830
2015-12-10 P, Open-market purchase Naked Brand Group Inc.NAKD 4,074, acquired Open Form 4 filing 0001062993-15-006677
2015-08-17 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 1,919, acquired Open Form 4 filing 0001209191-15-066453
2015-06-19 P, Open-market purchase Naked Brand Group Inc.NAKD 10,200, acquired Open Form 4 filing 0001062993-15-003510
2014-12-04 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 3,965, acquired Open Form 4 filing 0001209191-14-073174
2014-12-02 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 2 lines 3,050, acquired Open Form 4 filing 0001209191-14-072441
2014-12-01 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 2,000, acquired Open Form 4 filing 0001209191-14-072104
2014-11-25 P, Open-market purchase Corbus Pharmaceuticals Holdings, Inc.CRBP 2 lines 6,165, acquired Open Form 4 filing 0001209191-14-071385
2006-08-21 P, Open-market purchase Immune Response CorpIMNR 9,000, acquired Open Form 4 filing 0001294002-06-000032
2006-07-28 P, Open-market purchase Immune Response CorpIMNR 59,800, acquired Open Form 4 filing 0001294002-06-000024
2006-07-27 P, Open-market purchase Immune Response CorpIMNR 6,600, acquired Open Form 4 filing 0001294002-06-000024

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 52
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Hochman David P, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001292834

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.